KCM
Kingdon Capital Management Portfolio holdings
AUM
$518M
This Quarter Return
+7.1%
1 Year Return
+18.14%
3 Year Return
+127%
5 Year Return
+215.17%
10 Year Return
+696.09%
AUM
$1.9B
AUM Growth
+$1.9B
(+32%)
Cap. Flow
+$383M
Cap. Flow
% of AUM
20.22%
Top 10 Holdings %
Top 10 Hldgs %
26.09%
Holding
225
New
64
Increased
45
Reduced
33
Closed
52
Top Buys
| 1 |
NFX
Newfield Exploration
NFX
|
$53M |
| 2 |
Micron Technology
MU
|
$52.7M |
| 3 |
Halliburton
HAL
|
$44.4M |
| 4 |
WFT
Weatherford International plc
WFT
|
$34.5M |
| 5 |
HCA Healthcare
HCA
|
$30.2M |
Top Sells
| 1 |
Citigroup
C
|
$33.3M |
| 2 |
Fidelity National Financial
FNF
|
$23.6M |
| 3 |
McDonald's
MCD
|
$19.7M |
| 4 |
GAP
The Gap, Inc.
GAP
|
$16.6M |
| 5 |
Home Depot
HD
|
$16M |
Sector Composition
| 1 | Healthcare | 18.53% |
| 2 | Energy | 15.2% |
| 3 | Consumer Discretionary | 11.46% |
| 4 | Technology | 10.05% |
| 5 | Consumer Staples | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
76
DELISTED
MEDIVATION, INC.
MDVN
| $8.09M | 0.31% | 104,900 -65,000 | -38% | -$5.01M |
|
77
Universal Health Services
UHS
$11.6B
| $8.07M | 0.31% | 84,300 +25,000 | +42% | +$2.39M |
|
78
Heron Therapeutics
HRTX
$207M
| $7.86M | 0.3% | 638,315 +265,000 | +71% | +$3.26M |
|
79
Cigna
CI
$80.3B
| $7.82M | 0.3% | +85,000 | New | +$7.82M |
|
80
Fate Therapeutics
FATE
$120M
| $7.8M | 0.3% | 1,197,675 +84,200 | +8% | +$548K |
|
81
Humana
HUM
$36.5B
| $7.79M | 0.3% | +61,000 | New | +$7.79M |
|
82
Tyson Foods
TSN
$20.2B
| $7.7M | 0.3% | +205,000 | New | +$7.7M |
|
83
RPC Inc
RES
$1.05B
| $7.63M | 0.29% | 325,000 | – | – |
|
84
Starbucks
SBUX
$100B
| $7.35M | 0.28% | 95,000 -85,000 | -47% | -$6.58M |
|
|
AET
85
DELISTED
Aetna Inc
AET
| $7.3M | 0.28% | +90,000 | New | +$7.3M |
|
86
Eagle Materials
EXP
$7.49B
| $7.07M | 0.27% | 75,000 -60,000 | -44% | -$5.66M |
|
|
FLXN
87
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $6.91M | 0.27% | 514,466 +113,566 | +28% | +$1.53M |
|
88
Dollar General
DG
$23.9B
| $6.88M | 0.26% | +120,000 | New | +$6.88M |
|
89
Radware
RDWR
$1.08B
| $6.85M | 0.26% | 405,000 +15,000 | +4% | +$254K |
|
|
PLXP
90
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $6.82M | 0.26% | 710,000 +25,000 | +4% | +$240K |
|
91
Timken Company
TKR
$5.38B
| $6.78M | 0.26% | 100,000 | – | – |
|
|
ASPX
92
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $6.77M | 0.26% | 304,076 -97,657 | -24% | -$2.17M |
|
|
CODE
93
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
| $6.74M | 0.26% | +320,000 | New | +$6.74M |
|
94
Spectrum Brands
SPB
$1.38B
| $6.71M | 0.26% | +78,007 | New | +$6.71M |
|
|
SLCA
95
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $6.65M | 0.26% | 120,000 -30,000 | -20% | -$1.66M |
|
96
Interface
TILE
$1.56B
| $6.59M | 0.25% | 350,000 | – | – |
|
97
Donaldson
DCI
$9.28B
| $6.35M | 0.24% | 150,000 +50,000 | +50% | +$2.12M |
|
98
Caesarstone
CSTE
$49.1M
| $6.13M | 0.24% | +125,000 | New | +$6.13M |
|
99
Ribbon Communications
RBBN
$722M
| $6.1M | 0.23% | +1,700,000 | New | +$6.1M |
|
|
MJN
100
DELISTED
Mead Johnson Nutrition Company
MJN
| $6.06M | 0.23% | +65,000 | New | +$6.06M |
|